A steep fall in licensing income saw Biocon's net profit fall unexpectedly. Despite an 11% surge in net income, the company's net profit slipped 9% to Rs 70 crore.
Biotechnology company Biocon's consolidated net profit for the first quarter fell almost 9% from a year ago to Rs 70.05 crore, while net sales were up over 10% to Rs 441.68 crore.